Medicament for treating climacteric syndrome and preparation method thereof

Abstract

The invention relates to a medicine for treating climacteric syndrome, and a preparation method thereof. The medicine is prepared from the following raw material medicines: bupleurum, radix curcumae, prepared fleece flower roots, lilies, prepared rehmannia roots, multiflower knotweed vines, herba ecliptae, lotus plumule, spine date seeds and tortoise shells. The method comprises the following steps: 1) the lotus plumule and the tortoise shells are ground; 2) the lilies, the herba ecliptae, the spine date seeds and the multiflower knotweed vines are heated and extracted twice; extracts are merged, decompressed and concentrated; the bupleurum, the radix curcumae, the prepared rehmannia roots and the prepared fleece flower roots are heated and refluxed twice; the extracts are merged, are subjected to ethanol recovery, and are decompressed and concentrated into thick paste; 3) decoction dregs subjected to ethanol extraction are merged, mixed with water and decocted three times; decoction solutions are merged, filtered and kept to stand; supernatant is taken, concentrated to be at the relative density of 1.10 at a temperature of 80 DEG C, cooled to room temperature, mixed with the ethanol to ensure that the ethanol content reaches 70 percent, well mixed and kept to stand; and the supernatant is taken, subjected to ethanol extraction and concentrated into thin paste at the relative density of 1.24 at a temperature of 80 DEG C; and 4) the thin paste is added with fine powder in step 1 and the concentrated thick paste in step 2, is well mixed, dried, dispensed and ground into 100-mesh fine powder, and separately packaged into 0.5-gram capsules.

Description

technical field [0001] The invention relates to a medicine for treating menopausal syndrome, in particular to a medicine for treating menopausal syndrome prepared from Chinese herbal medicine and a preparation method thereof. Background technique [0002] In recent years, the incidence of menopausal syndrome has risen and we have experienced the treatment and observation of this disease. We have found that most of the drugs used in the treatment of patients are mainly Western medicines for sleeping. Moreover, some Western medicines inhibit the cerebral cortex and can only control and relieve the symptoms at that time. Symptoms, poor curative effect, induce artificial weakening of antibodies, and delay the best treatment period. Tracing it to its cause is that the law of "treating both the symptoms and the root causes and treating the disease must seek the root" has not been brought into full play. Contents of the invention [0003] The purpose of the present invention is ...

AI Technical Summary

Problems solved by technology

[0002] In recent years, the incidence of menopausal syndrome has increased and we have experienced the treatment and observation of this disease. We have found that most of the drugs used in the treatment of patients are mainly Western medicines for sleeping. Moreover, some Western medicines inhibit the cerebral cortex and can only control and relieve the symptoms at that time. Symptoms, poor curative effect, induce artificial weakening of antibodies, and delay the best treatment period

The reason is that the principle of "treating both the symptoms and the root causes and treating the disease must be based on the root" has not been brought into full play.